A. Leone

发表

Severity of illness and outcome in patients with end-stage idiopathic pulmonary fibrosis requiring mechanical ventilation.

A. Vestri, C. Terzano, G. Paone, 2010, Chest.

Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.

P. Steeg, A. Leone, U. Flatow, 1993, Oncogene.

Potential usefulness of a combination of inflammatory markers in identifying patients with sarcoidosis and monitoring respiratory functional worsening.

G. Galluccio, G. D. Di Tanna, A. Vestri, 2012, American journal of clinical pathology.

Long-term disease-free survival of a patient with synchronous bilateral lung adenocarcinoma displaying different EGFR and C-MYC molecular characteristics.

F. de Marinis, P. Graziano, A. Mancuso, 2011, Chest.

NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors.

P. Steeg, R. Lidereau, C. Cropp, 1994, Journal of the National Cancer Institute.

Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers

A. Mannocci, C. Terzano, G. Paone, 2012, Inflammation Research.

H 2 Gene , nm 23 Identification of a Second Human Updated

P. Steeg, C. King, J. Stahl, 2006 .

mdm2-p53 Interaction: Lack of Correlation with the Response to 5-Fluorouracil in Advanced Colorectal Cancer

A. Paradiso, M. de Lena, N. Silvestris, 2002, Oncology.

Nm23 and breast cancer metastasis

P. Steeg, M. Benedict, N. MacDonald, 2004, Breast Cancer Research and Treatment.

Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers

A. Mannocci, C. Terzano, G. Paone, 2013, Inflammation Research.

Tumor metastasis and nm23: current concepts.

P. Steeg, K. Cohn, A. Leone, 1991, Cancer cells.

Prognostic significance of the loss of heterozygosity of nm23‐h1 and p53 genes in human colorectal carcinomas

F. Bosch, E. Campo, P. Jares, 1994, Cancer.

Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.

D. Stram, P. Steeg, D. Slamon, 1993, Oncogene.

Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma

P. Steeg, K. Cohn, W. Solomon, 1991, The Lancet.

Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells

L. Liotta, P. Steeg, I. Margulies, 1991, Cell.

Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma)

S. Garcovich, G. Massi, V. Arena, 2012, Virchows Archiv.

nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma.

S. Petroni, C. Campobasso, A. Leone, 2001, International journal of oncology.

Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.

M. Marone, G. Scambia, C. Giannitelli, 1996, British Journal of Cancer.

The Role of the Pathologist in the Management of Patients with Crohn’s Disease

A. Leone, M. C. Macciomei, R. Pisa, 2010 .

Somatic allelic deletion of nm23 in human cancer.

L. Liotta, R. Rees, W. Linehan, 1991, Cancer research.

Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice

M. Papotti, S. Novello, A. Sapino, 2021, Journal of Clinical Pathology.

Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications

A. Marchetti, F. Buttitta, F. Mucilli, 2012, PloS one.

The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.

G. Rossi, P. Graziano, M. Migaldi, 2013, Seminars in diagnostic pathology.

Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation

S. Girlando, A. Ulivieri, A. Mancuso, 2015, Oncotarget.

nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.

M. Marone, G. Scambia, C. Giannitelli, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advances in Brief Identification of a Second Human nm 23 Gene , nm 23-H 2

P. Steeg, C. King, A. Leone, 2006 .

BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1).

E. Campo, J. Yagüe, P. Steeg, 1991, Nucleic acids research.

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

P. Graziano, L. Muscarella, L. Grillo, 2022, Cancers.

The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma

V. Poulaki, N. Mitsiades, Y. Ward, 2001, Oncogene.

Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study

G. Ravagnan, S. Greco, M. Fuggetta, 2019, Scientifica.

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients

A. Vestri, C. Terzano, G. Paone, 2011, Disease markers.

Human neutrophil peptides sputum levels in symptomatic smokers and COPD patients.

G. Giannunzio, C. Terzano, G. Paone, 2011, European review for medical and pharmacological sciences.

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study

G. Troncone, C. Bellevicine, U. Malapelle, 2019, Journal of Clinical Pathology.

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti‐angiogenic treatment

C. Sternberg, F. Calabrò, L. Cerbone, 2012, BJU international.

Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis.

G. Galluccio, P. Graziano, E. Girardi, 2009, Chest.

Nucleoside diphosphate kinases, nm23, and tumor metastasis: possible biochemical mechanisms.

L. Liotta, P. Steeg, A. Golden, 1992, Cancer treatment and research.

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene.

Y. Ichinose, P. Graziano, G. Toyokawa, 2013, Lung cancer.

Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform

A. Rossi, P. Graziano, L. Muscarella, 2021, Journal of Clinical Pathology.

Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey.

R. Labianca, F. Cavalli, C. Sternberg, 2007, Anticancer research.

Highly sensitive detection of EGFR T790M mutation in pre-TKI specimens of EGFR-mutated NSCLC: in cis, in trans, or a different clone?

A. Leone, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of EGFR mutations in lung sarcomatoid carcinoma

F. de Marinis, P. Graziano, A. Mancuso, 2011, International journal of cancer.

EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology.

G. Pelosi, F. de Marinis, P. Graziano, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients

A. Rossi, P. Graziano, A. Mancuso, 2019, American journal of clinical oncology.

Patient with colorectal cancer with heterogeneous KRAS molecular status responding to cetuximab-based chemotherapy.

L. Cerbone, F. Recine, A. Mancuso, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of EGFR mutations in lung sarcomatoid carcinoma

F. de Marinis, P. Graziano, A. Mancuso, 2011, International journal of cancer.

Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey.

R. Labianca, F. Cavalli, C. Sternberg, 2010, Anticancer research.

nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique.

A. Paradiso, S. Petroni, M. de Lena, 1998, International journal of oncology.